Biocompatible Liposomes for Drug Delivery: Materials and Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 December 2025 | Viewed by 59
Special Issue Editors
Interests: drug delivery to the lung; formulations for dry powder inhalers; formulations for nebulisers; nanosuspension for inhaled
Special Issues, Collections and Topics in MDPI journals
Interests: drug discovery; translational; medicine; molecular; genetics; pharmacology; hypertension; TGFbeta
Special Issues, Collections and Topics in MDPI journals
Interests: Inhalation; liposome; prodrug; nanomedicine (lipid carriers for drug delivery)
Interests: nanotechnology; formulation design and development; nanoliposomes; novel drug delivery systems; inhalable therapeutics; pharmacokinetics; translational medicine; biopharmaceutics; targeted drug delivery; and smart drug delivery systems
Special Issue Information
Dear Colleagues,
Liposomes are artificial self-assembled closed spherical bilayer systems made of phospholipids. Due to their biocompatibility, varied structure, composition and membrane-like properties, they are widely used for a variety of applications. These include enhancing bioavailability, sustained release, and targeted delivery in the pharmaceutical and cosmetic industry and offer a flexible solution to some of the crucial challenges faced by these industries. The added advantage is its ability to simultaneously deliver substances with varying solubility, i.e., hydrophobic and hydrophilic compounds. However, the use of liposomes is limited to some extent by shorter half-life, leakage, and fusion of the drugs during transport within the body, leading to poor targeting. Research in liposomes is fast expanding with the aim of developing new and efficient ways to overcome these challenges and open new horizons in therapeutics and cosmetics.
This Special Issue of Pharmaceutics will focus on the recent advances in the area of liposome delivery with reference to the following topics, but will not be limited to:
- Biocompatibility and bioavailability;
- Challenges of using liposomal drug delivery methods;
- Liposomes and cancer therapeutics;
- Liposomes and cosmetic preparations;
- Liposomes for pulmonary delivery;
- Liposomes for gene therapy and vaccines;
- Novel liposomal delivery methods.
Dr. Khaled Assi
Dr. Talat Nasim
Dr. Rajendran C. Gopalan
Guest Editors
Dr. Fatma Haddad
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inhalation
- liposome
- prodrug
- nanomedicine (lipid carriers for drug delivery)
- biocompatible liposomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
